Drug interactions with St John's wort : mechanisms and clinical implications
- PMID: 15350151
- DOI: 10.2165/00002018-200427110-00003
Drug interactions with St John's wort : mechanisms and clinical implications
Abstract
The purpose of this paper is to review preclinical and clinical evidence relating to drug interactions with preparations of the medicinal herb St John's wort (Hypericum perforatum). A systematic literature search was carried out in three electronic databases up to June 2004. Information about case reports classified as St John's wort drug interactions was retrieved from the WHO Collaborating Centre for International Drug Monitoring and from the UK Medicines and Healthcare products Regulatory Agency in June 2003. Against the background of proven efficacy in mild to moderate depressive disorders and an excellent tolerability profile in monotherapy, there is sufficient evidence from interaction studies and case reports to suggest that St John's wort may induce the cytochrome P450 (CYP) 3A4 enzyme system and the P-glycoprotein drug transporter in a clinically relevant manner, thereby reducing efficacy of co-medications. Drugs most prominently affected and contraindicated for concomitant use with St John's wort are metabolised via both CYP3A4 and P-glycoprotein pathways, including HIV protease inhibitors, HIV non-nucleoside reverse transcriptase inhibitors (only CYP3A4), the immunosuppressants ciclosporin and tacrolimus, and the antineoplastic agents irinotecan and imatinib mesylate. Efficacy of hormonal contraceptives may be impaired as reflected by case reports of irregular bleedings and unwanted pregnancies. Drugs with a narrow therapeutic index should be monitored more closely when St John's wort is added, discontinued or the dosage is changed. The St John's wort constituent hyperforin is probably responsible for CYP3A4 induction via activation of a nuclear steroid/pregnane and xenobiotic receptor (SXR/PXR) and hypericin may be assumed to be the P-glycoprotein inducing compound, although the available evidence is less convincing. Combinations of St John's wort with serotonergic agents and other antidepressants should be restricted to prescription-only, by experienced clinicians, due to potential central pharmacodynamic interactions. In conclusion, providing certain precautions and contraindications are followed, and adequate information is given to healthcare professionals and patients, the safe and effective use of quality-tested St John's wort products can be ensured.
Similar articles
-
About the cover: St. John's wort.J Soc Integr Oncol. 2006 Winter;4(1):52-5. J Soc Integr Oncol. 2006. PMID: 16737673 Review.
-
St John's wort and depression: slight efficacy at best, many drug interactions.Prescrire Int. 2004 Oct;13(73):187-92. Prescrire Int. 2004. PMID: 15499702
-
Pharmacokinetic interactions of drugs with St John's wort.J Psychopharmacol. 2004 Jun;18(2):262-76. doi: 10.1177/0269881104042632. J Psychopharmacol. 2004. PMID: 15260917 Review.
-
The emerging recognition of herb-drug interactions with a focus on St. John's wort (Hypericum perforatum).Psychopharmacol Bull. 2001 Winter;35(1):53-64. Psychopharmacol Bull. 2001. PMID: 12397870 Review.
-
St John's wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties.J Pharm Pharmacol. 2001 May;53(5):583-600. doi: 10.1211/0022357011775910. J Pharm Pharmacol. 2001. PMID: 11370698 Review.
Cited by
-
Activation of PXR causes drug interactions with Paxlovid in transgenic mice.Acta Pharm Sin B. 2023 Nov;13(11):4502-4510. doi: 10.1016/j.apsb.2023.08.001. Epub 2023 Aug 7. Acta Pharm Sin B. 2023. PMID: 37969744 Free PMC article.
-
Safety Concerns Related to the Simultaneous Use of Prescription or Over-the-Counter Medications and Herbal Medicinal Products: Survey Results among Latvian Citizens.Int J Environ Res Public Health. 2023 Aug 9;20(16):6551. doi: 10.3390/ijerph20166551. Int J Environ Res Public Health. 2023. PMID: 37623137 Free PMC article.
-
Controversial Interactions of Tacrolimus with Dietary Supplements, Herbs and Food.Pharmaceutics. 2022 Oct 10;14(10):2154. doi: 10.3390/pharmaceutics14102154. Pharmaceutics. 2022. PMID: 36297591 Free PMC article. Review.
-
Perspectives of East Asian patients and physicians on complementary and alternative medicine use for inflammatory bowel disease: results of a cross-sectional, multinational study.Intest Res. 2022 Apr;20(2):192-202. doi: 10.5217/ir.2020.00150. Epub 2022 Apr 29. Intest Res. 2022. PMID: 35508953 Free PMC article.
-
Antiproliferative Effects of St. John's Wort, Its Derivatives, and Other Hypericum Species in Hematologic Malignancies.Int J Mol Sci. 2020 Dec 25;22(1):146. doi: 10.3390/ijms22010146. Int J Mol Sci. 2020. PMID: 33375664 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical